Management of patients with symptomatic gastroesophageal reflux disease: a primary care perspective. Pantoprazole therapy in the long-term management of severe acid peptic disease: clinical efficacy, safety, serum gastrin, gastric histology, and endocrine cell studies. This is because GERD is a chronic, usually lifelong disease that often relapses once treatment is stopped. Carlsson R, Dent J, Watts R, et al. Pare P, Armstrong D, Pericak D, et al. Bloom BS, Jayadevappa R, Wahl P, et al. Note: *Statistically significant difference;The intensity of symptoms was rated on a 4 point-scale (0: none, 1: mild, 2: moderate, 3: severe). Excess gastroesophageal reflux in patients with hiatus hernia is caused by mechanisms other than transient LES relaxations.
Infection with Helicobacter pylori does not appear to contribute to the development of GERD (Csendes et al 1997; Labenz and Malfertheiner 1997; Raghunath et al 2003; Sharma and Vakil 2003). Maintenance therapy with pantoprazole 20 mg prevents relapse of reflux oesophagitis. A 20-year follow-up of 2306 patients who received symptom-driven antireflux treatment indicated that only one patient with a normal baseline mucosa developed esophageal stricture requiring dilation (0.08%), but that 18 patients with an erosive baseline mucosa were affected (1.9%).
35, 58095 Hagen, Germany Tel +49 2331 201 2246 Fax +49 2331 201 2309 Email, pantoprazole, proton pump inhibitor, erosive esophagitis, gastroesophageal reflux disease, tolerability, efficacy. As few differences in safety or efficacy have been reported between the available PPIs, the decision to select one PPI over another is most likely to be based on the agents acquisition costs, formulations, Food and Drug Administration-labeled indications, and overall safety profiles (Welage and Berardi 2000). Pharmacokinetic drug interaction profiles of proton pump inhibitors. This medication may be prescribed for other uses; ask your doctor or pharmacist for more information. Recently, a new GERD specific, reliable, sensitive, and validated questionnaire for the evaluation of health-related quality of life was developed. In addition, oral pantoprazole has been shown to improve the quality of life of patients with GERD and is associated with high levels of patient satisfaction with therapy. What side effects can this medication cause?
DeVault K, Malagelada J, Holtmann G, et al. Determining the cost of gastroesophageal reflux disease: a decision analytic model. PPIs thus produce a considerable but dose-dependent elevation of gastric pH (Dajani 2000). 40 mg pantoprazole and 40 mg esomeprazole are equivalent in the healing of esophageal lesions and relief from gastroesophageal reflux disease-related symptoms. Similarly, in Europe, PPI therapy demonstrates similar efficacy to open antireflux surgery in terms of prevalence of Barretts esophagus or strictures requiring dilatation, incidence of GERD-associated symptoms or quality of life at 3 years follow up (Lundell et al 2000), but after 5 years is associated with lower total medical costs (operation, endoscopy, visits to the outpatient clinic, and medication) for chronic GERD (Myrvold et al 2001). Pilotto A, Leandro G, Franceschi M. Short- and long-term therapy for reflux oesophagitis in the elderly: a multi-centre, placebo-controlled study with pantoprazole. Adverse events most commonly experienced by patients receiving pantoprazole in these long-term trials are those expected in patients receiving PPI therapy.
Kaspari S, Biedermann A, Mey J. Results of the patient unmet needs survey. However, long-term high-dose PPI therapy is the first-line approach to controlling these extraesophageal GERD symptoms (Halstead 2005). Shaw MJ, Fendrick AM, Kane RL, et al. More frequently, elderly patients with GERD report symptoms such as dysphagia, vomiting and respiratory difficulties, anorexia, weight loss, and anemia-melena (Pilotto and Franceschi 2003). Lassen A, Hallas J, de Muckadell OB.
The presence of GERD is also associated with reduced work productivity for affected individuals in the labor force (Henke et al 2000; Sandler et al 2002). Gastroesophageal reflux disease (GERD) is a chronic, relapsing disease that infrequently progresses (Sontag et al 2006) but is associated with a range of potentially serious esophageal complications (esophageal ulcer, esophageal stricture or obstruction, Barretts esophagus or esophageal cancer) and extra-esophageal diseases such as respiratory problems, chest pain, angina, and increased mortality (Ruigomez et al 2004). The https:// ensures that you are connecting to the Pantoprazole 40 mg is at least comparable to esomeprazole 40 mg in achieving endoscopically confirmed healing and symptom relief of gastroesophageal reflux disease (GERD) after 4, 8 and 12 weeks of treatment. Thus GERD results in a significant cost burden. Time trends in cost of caring for people with gastroesophageal reflux disease. What special dietary instructions should I follow? Csendes A, Smok G, Cerda G, et al.
Initiation of empiric therapy with acid suppressive therapy, usually a PPI, in patients with symptoms consistent with GERD is an efficient and acceptable method to confirm GERD; this method lacks specificity (Numans et al 2004). 
Simply put, GERD has been defined as a condition which develops when the reflux of stomach contents causes troublesome symptoms and/or complications (Vakil et al 2006). Netzer P, Brabetz-Hofliger A, Brundler R, et al. tell your doctor and pharmacist if you are allergic to omeprazole, dexlansoprazole (Dexilant), esomeprazole (Nexium), lansoprazole (Prevacid), pantoprazole (Protonix), rabeprazole (Aciphex), any other medications, or any of the ingredients in the omeprazole product you will be taking. tell your doctor if you are taking rilpivirine (Edurant, in Cabenuva, Complera, Odefsey).
Omeprazole is in a class of medications called proton-pump inhibitors. Pantoprazole has also demonstrated efficacy in difficult-to-treat patients. Gastroesophageal reflux disease is one of the most common chronic gastrointestinal disorders (Haag and Holtmann 2003). Scholten T, Gatz G, Hole U. Once-daily pantoprazole 40 mg and esomeprazole 40 mg have equivalent overall efficacy in relieving GERD-related symptoms. Fendrick AM. These results show that pantoprazole is highly effective for healing and reducing the relapse of erosive esophagitis, and that discontinuing active treatment after 6 months is associated with a significant increase in the risk of relapse.
Gillessen A, Beil W, Modlin IM, et al. Prevalence of gastro-oesophageal reflux disease in general practice.
Long-term management of gastro-oesophageal reflux disease with omeprazole or open antireflux surgery: results of a prospective, randomized clinical trial. International GORD Study Group. Escourrou J, Deprez P, Saggioro A, et al. Revicki DA, Wood M, Maton PN, et al. Control of heartburn strongly predicts improvement in health-related quality of life during the acute treatment of GERD (Pare et al 2003). As no pharmaceutical agent can fully correct the motor dysfunction responsible for acid reflux into the esophagus, acid suppression remains the most effective way to relieve symptoms and to promote healing of esophagitis in patients with GERD (Orlando 1997).
Kaplan-Machlis B, Spiegler GE, Revicki DA. In case of overdose, call the poison control helpline at 1-800-222-1222. Evaluation of health-related quality of life in gastroesophageal reflux disease patients before and after treatment with pantoprazole.
Donnellan C, Sharma N, Preston C, et al. Orlando RC.
If needed, additional 14-day treatments may be repeated, not more often than once every 4 months. Relevance of norm values as part of the documentation of quality of life instruments for use in upper gastrointestinal disease. The Nordic GORD Study Group. Proton pump inhibitors are accepted as the most effective initial and maintenance treatment for GERD.
Drink the entire mixture within 30 minutes. blisters, peeling, or bleeding skin; sores on the lips, nose, mouth, or genitals; swollen glands; shortness of breath; fever; or flu-like symptoms, rash; hives; itching; swelling of the eyes, face, lips, mouth, throat, or tongue; difficulty breathing or swallowing; or hoarseness, irregular, fast, or pounding heartbeat; muscle spasms; uncontrollable shaking of a part of the body; excessive tiredness; lightheadedness; dizziness; or seizures, severe diarrhea with watery stools, stomach pain, or fever that does not go away, new or worsening joint pain; rash on cheeks or arms that is sensitive to sunlight, increased or decreased urination, blood in urine, fatigue, nausea, loss of appetite, fever, rash, or joint pain, Talicia (as a combination product containing Amoxicillin, Omeprazole, Rifabutin). Fass R, Ofman JJ, Sampliner RE, et al. Complete resolution of heartburn symptoms and health-related quality of life in patients with gastrooesophageal reflux disease. The safety profile of pantoprazole in elderly patients is discussed later in this review. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location one that is up and away and out of their sight and reach.
If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911. Follow the directions on your prescription label or the package label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Johnson DA, Fennerty MB. The data available indicate that pantoprazole 20 mg has similar efficacy to omeprazole 20 mg for maintaining endoscopic and symptomatic remission in patients with healed erosive esophagitis (Lauritsen et al 2000). Safety and efficacy of pantoprazole 40 mg daily as relapse prophylaxis in patients with healed reflux oesophagitis-a 2-year follow-up. Esomeprazole 20 mg vs. pantoprazole 20 mg for maintenance therapy of healed erosive oesophagitis: results from the EXPO study. tell your doctor what herbal products you are taking, especially St. John's wort. Fass R, Ofman JJ, Gralnek IM, et al. The impact of GERD is most striking on measures of pain, mental health, and social function (Revicki et al 1998; Enck et al 1999; Farup et al 2001a). Sharma P, Vakil N. Review article: Helicobacter pylori and reflux disease. Dent J, Brun J, Fendrick A, et al. Results of numerous clinical trials indicate that oral pantoprazole is safe and well tolerated for short-term treatment of GERD and for longer term maintenance therapy in patients with healed erosive esophagitis. Crawley JA, Maclin Schmitt C. How satisfied are chronic heartburn sufferers with their prescription medications? Successful treatment of elderly patients with erosive esophagitis (EE) using pantoprazole 40 mg. DeVault KR, Castell DO. Nonerosive GERD can progress to erosive disease in susceptible patients (Orlando 2006) although initial severity of GERD is maintained in most patients (Vakil et al 2006). official website and that any information you provide is encrypted Evaluation of omeprazole, lansoprazole, pantoprazole, and rabeprazole in the treatment of acid-related diseases. Robinson M, Horn J.
Progress with proton pump inhibition. In these studies, oral pantoprazole at doses of 20 mg and 40 mg once daily for 8 weeks rapidly reduced symptom scores in 53 children aged 5 to 11 years with erosive or histological esophagitis (p < 0.001) (Tolia et al 2006) and in 136 adolescents aged 12 to 16 years with clinically diagnosed GERD (p < 0.001) (Tsou et al 2006). Treating patients with GERD is about 2-fold more costly than treating those without GERD (Bloom et al 2001).
Thus, monitoring of serum gastrin levels and fundic enterochromaffin-like cells is of no clinical relevance even during long-term therapy with PPIs (Arnold 1994).
Infection with Helicobacter pylori does not appear to contribute to the development of GERD (Csendes et al 1997; Labenz and Malfertheiner 1997; Raghunath et al 2003; Sharma and Vakil 2003). Maintenance therapy with pantoprazole 20 mg prevents relapse of reflux oesophagitis. A 20-year follow-up of 2306 patients who received symptom-driven antireflux treatment indicated that only one patient with a normal baseline mucosa developed esophageal stricture requiring dilation (0.08%), but that 18 patients with an erosive baseline mucosa were affected (1.9%).
35, 58095 Hagen, Germany Tel +49 2331 201 2246 Fax +49 2331 201 2309 Email, pantoprazole, proton pump inhibitor, erosive esophagitis, gastroesophageal reflux disease, tolerability, efficacy. As few differences in safety or efficacy have been reported between the available PPIs, the decision to select one PPI over another is most likely to be based on the agents acquisition costs, formulations, Food and Drug Administration-labeled indications, and overall safety profiles (Welage and Berardi 2000). Pharmacokinetic drug interaction profiles of proton pump inhibitors. This medication may be prescribed for other uses; ask your doctor or pharmacist for more information. Recently, a new GERD specific, reliable, sensitive, and validated questionnaire for the evaluation of health-related quality of life was developed. In addition, oral pantoprazole has been shown to improve the quality of life of patients with GERD and is associated with high levels of patient satisfaction with therapy. What side effects can this medication cause?
DeVault K, Malagelada J, Holtmann G, et al. Determining the cost of gastroesophageal reflux disease: a decision analytic model. PPIs thus produce a considerable but dose-dependent elevation of gastric pH (Dajani 2000). 40 mg pantoprazole and 40 mg esomeprazole are equivalent in the healing of esophageal lesions and relief from gastroesophageal reflux disease-related symptoms. Similarly, in Europe, PPI therapy demonstrates similar efficacy to open antireflux surgery in terms of prevalence of Barretts esophagus or strictures requiring dilatation, incidence of GERD-associated symptoms or quality of life at 3 years follow up (Lundell et al 2000), but after 5 years is associated with lower total medical costs (operation, endoscopy, visits to the outpatient clinic, and medication) for chronic GERD (Myrvold et al 2001). Pilotto A, Leandro G, Franceschi M. Short- and long-term therapy for reflux oesophagitis in the elderly: a multi-centre, placebo-controlled study with pantoprazole. Adverse events most commonly experienced by patients receiving pantoprazole in these long-term trials are those expected in patients receiving PPI therapy.
Kaspari S, Biedermann A, Mey J. Results of the patient unmet needs survey. However, long-term high-dose PPI therapy is the first-line approach to controlling these extraesophageal GERD symptoms (Halstead 2005). Shaw MJ, Fendrick AM, Kane RL, et al. More frequently, elderly patients with GERD report symptoms such as dysphagia, vomiting and respiratory difficulties, anorexia, weight loss, and anemia-melena (Pilotto and Franceschi 2003). Lassen A, Hallas J, de Muckadell OB.
The presence of GERD is also associated with reduced work productivity for affected individuals in the labor force (Henke et al 2000; Sandler et al 2002). Gastroesophageal reflux disease (GERD) is a chronic, relapsing disease that infrequently progresses (Sontag et al 2006) but is associated with a range of potentially serious esophageal complications (esophageal ulcer, esophageal stricture or obstruction, Barretts esophagus or esophageal cancer) and extra-esophageal diseases such as respiratory problems, chest pain, angina, and increased mortality (Ruigomez et al 2004). The https:// ensures that you are connecting to the Pantoprazole 40 mg is at least comparable to esomeprazole 40 mg in achieving endoscopically confirmed healing and symptom relief of gastroesophageal reflux disease (GERD) after 4, 8 and 12 weeks of treatment. Thus GERD results in a significant cost burden. Time trends in cost of caring for people with gastroesophageal reflux disease. What special dietary instructions should I follow? Csendes A, Smok G, Cerda G, et al.
Initiation of empiric therapy with acid suppressive therapy, usually a PPI, in patients with symptoms consistent with GERD is an efficient and acceptable method to confirm GERD; this method lacks specificity (Numans et al 2004). Simply put, GERD has been defined as a condition which develops when the reflux of stomach contents causes troublesome symptoms and/or complications (Vakil et al 2006). Netzer P, Brabetz-Hofliger A, Brundler R, et al. tell your doctor and pharmacist if you are allergic to omeprazole, dexlansoprazole (Dexilant), esomeprazole (Nexium), lansoprazole (Prevacid), pantoprazole (Protonix), rabeprazole (Aciphex), any other medications, or any of the ingredients in the omeprazole product you will be taking. tell your doctor if you are taking rilpivirine (Edurant, in Cabenuva, Complera, Odefsey). Omeprazole is in a class of medications called proton-pump inhibitors. Pantoprazole has also demonstrated efficacy in difficult-to-treat patients. Gastroesophageal reflux disease is one of the most common chronic gastrointestinal disorders (Haag and Holtmann 2003). Scholten T, Gatz G, Hole U. Once-daily pantoprazole 40 mg and esomeprazole 40 mg have equivalent overall efficacy in relieving GERD-related symptoms. Fendrick AM. These results show that pantoprazole is highly effective for healing and reducing the relapse of erosive esophagitis, and that discontinuing active treatment after 6 months is associated with a significant increase in the risk of relapse.
Gillessen A, Beil W, Modlin IM, et al. Prevalence of gastro-oesophageal reflux disease in general practice.
Long-term management of gastro-oesophageal reflux disease with omeprazole or open antireflux surgery: results of a prospective, randomized clinical trial. International GORD Study Group. Escourrou J, Deprez P, Saggioro A, et al. Revicki DA, Wood M, Maton PN, et al. Control of heartburn strongly predicts improvement in health-related quality of life during the acute treatment of GERD (Pare et al 2003). As no pharmaceutical agent can fully correct the motor dysfunction responsible for acid reflux into the esophagus, acid suppression remains the most effective way to relieve symptoms and to promote healing of esophagitis in patients with GERD (Orlando 1997). Kaplan-Machlis B, Spiegler GE, Revicki DA. In case of overdose, call the poison control helpline at 1-800-222-1222. Evaluation of health-related quality of life in gastroesophageal reflux disease patients before and after treatment with pantoprazole.
Donnellan C, Sharma N, Preston C, et al. Orlando RC.
If needed, additional 14-day treatments may be repeated, not more often than once every 4 months. Relevance of norm values as part of the documentation of quality of life instruments for use in upper gastrointestinal disease. The Nordic GORD Study Group. Proton pump inhibitors are accepted as the most effective initial and maintenance treatment for GERD.
Drink the entire mixture within 30 minutes. blisters, peeling, or bleeding skin; sores on the lips, nose, mouth, or genitals; swollen glands; shortness of breath; fever; or flu-like symptoms, rash; hives; itching; swelling of the eyes, face, lips, mouth, throat, or tongue; difficulty breathing or swallowing; or hoarseness, irregular, fast, or pounding heartbeat; muscle spasms; uncontrollable shaking of a part of the body; excessive tiredness; lightheadedness; dizziness; or seizures, severe diarrhea with watery stools, stomach pain, or fever that does not go away, new or worsening joint pain; rash on cheeks or arms that is sensitive to sunlight, increased or decreased urination, blood in urine, fatigue, nausea, loss of appetite, fever, rash, or joint pain, Talicia (as a combination product containing Amoxicillin, Omeprazole, Rifabutin). Fass R, Ofman JJ, Sampliner RE, et al. Complete resolution of heartburn symptoms and health-related quality of life in patients with gastrooesophageal reflux disease. The safety profile of pantoprazole in elderly patients is discussed later in this review. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location one that is up and away and out of their sight and reach.
If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911. Follow the directions on your prescription label or the package label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Johnson DA, Fennerty MB. The data available indicate that pantoprazole 20 mg has similar efficacy to omeprazole 20 mg for maintaining endoscopic and symptomatic remission in patients with healed erosive esophagitis (Lauritsen et al 2000). Safety and efficacy of pantoprazole 40 mg daily as relapse prophylaxis in patients with healed reflux oesophagitis-a 2-year follow-up. Esomeprazole 20 mg vs. pantoprazole 20 mg for maintenance therapy of healed erosive oesophagitis: results from the EXPO study. tell your doctor what herbal products you are taking, especially St. John's wort. Fass R, Ofman JJ, Gralnek IM, et al. The impact of GERD is most striking on measures of pain, mental health, and social function (Revicki et al 1998; Enck et al 1999; Farup et al 2001a). Sharma P, Vakil N. Review article: Helicobacter pylori and reflux disease. Dent J, Brun J, Fendrick A, et al. Results of numerous clinical trials indicate that oral pantoprazole is safe and well tolerated for short-term treatment of GERD and for longer term maintenance therapy in patients with healed erosive esophagitis. Crawley JA, Maclin Schmitt C. How satisfied are chronic heartburn sufferers with their prescription medications? Successful treatment of elderly patients with erosive esophagitis (EE) using pantoprazole 40 mg. DeVault KR, Castell DO. Nonerosive GERD can progress to erosive disease in susceptible patients (Orlando 2006) although initial severity of GERD is maintained in most patients (Vakil et al 2006). official website and that any information you provide is encrypted Evaluation of omeprazole, lansoprazole, pantoprazole, and rabeprazole in the treatment of acid-related diseases. Robinson M, Horn J.
Progress with proton pump inhibition. In these studies, oral pantoprazole at doses of 20 mg and 40 mg once daily for 8 weeks rapidly reduced symptom scores in 53 children aged 5 to 11 years with erosive or histological esophagitis (p < 0.001) (Tolia et al 2006) and in 136 adolescents aged 12 to 16 years with clinically diagnosed GERD (p < 0.001) (Tsou et al 2006). Treating patients with GERD is about 2-fold more costly than treating those without GERD (Bloom et al 2001).
Thus, monitoring of serum gastrin levels and fundic enterochromaffin-like cells is of no clinical relevance even during long-term therapy with PPIs (Arnold 1994).